BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Bing S, Dong M, Lu X, Xiong Y. Targeting ion channels for the treatment of lung cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188629. [PMID: 34610420 DOI: 10.1016/j.bbcan.2021.188629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiong W, Fan H, Zeng Q, Deng Z, Li G, Lu W, Zhang B, Lai S, Chen X, Xu X. The in vitro anticancer effects of FS48 from salivary glands of Xenopsylla cheopis on NCI-H460 cells via its blockage of voltage-gated K(+) channels. Acta Pharm 2023;73:145-55. [PMID: 36692462 DOI: 10.2478/acph-2023-0010] [Reference Citation Analysis]
2 Wang Y, Zhou H, Sun Y, Huang Y. Acid-sensing ion channel 1: potential therapeutic target for tumor. Biomedicine & Pharmacotherapy 2022;155:113835. [DOI: 10.1016/j.biopha.2022.113835] [Reference Citation Analysis]
3 Gould HJ, Paul D. Cancer as a Channelopathy—Appreciation of Complimentary Pathways Provides a Different Perspective for Developing Treatments. Cancers 2022;14:4627. [DOI: 10.3390/cancers14194627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dong M, Zheng G, Gao F, Li M, Zhong C. Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity. Front Pharmacol 2022;13:834317. [PMID: 35153798 DOI: 10.3389/fphar.2022.834317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]